Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IB, Investigator-Initiated, Open-Label, Multi-Center Trial of Rituximab With or Without Methotrexate In Subjects With Psoriatic Arthritis and Psoriasis

NCT00509678 is registered in ClinicalTrials.gov with Swedish Medical Center as lead sponsor.

NCT NCT00509678
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00509678 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IB, Investigator-Initiated, Open-Label, Multi-Center Trial of Rituximab With or Without Methotrexate In Subjects With Psoriatic Arthritis and Psoriasis
Lead sponsor
Swedish Medical Center
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2006
Completion date
March 31, 2010
Enrollment
6 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

psoriatic arthritis